These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7475634)

  • 1. Use of long-acting contraceptives.
    Vekemans M
    Lancet; 1995 Oct; 346(8983):1165. PubMed ID: 7475634
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of levonorgestrel implants on the periodontium.
    Kazerooni T; Ghaffarpasand F; Rastegar N; Kazerooni Y
    Int J Gynaecol Obstet; 2008 Dec; 103(3):255-6. PubMed ID: 18804758
    [No Abstract]   [Full Text] [Related]  

  • 3. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of cardiovascular disease among the oral contraceptive users in Kermanshah City of Iran.
    Malek-Khosravi S
    J Pak Med Assoc; 2008 Aug; 58(8):473-4. PubMed ID: 18822656
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of long-acting contraceptives in adolescents.
    Harel Z; Cromer B
    Pediatr Clin North Am; 1999 Aug; 46(4):719-32. PubMed ID: 10494253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonorgestrel.
    Nurs Times; 2005 Jan 11-17; 101(2):31. PubMed ID: 15688918
    [No Abstract]   [Full Text] [Related]  

  • 7. Removal of non-palpable etonogestrel implants.
    Mansour D; Walling M; Glenn D; Egarter C; Graesslin O; Herbst J; Fraser IS
    J Fam Plann Reprod Health Care; 2008 Apr; 34(2):89-91. PubMed ID: 18413020
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time for plan B.
    Nature; 2013 Apr; 496(7444):138. PubMed ID: 23586095
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel estrogen-free oral contraceptive pill for women: multicentre, double-blind, randomized controlled trial of mifepristone and progestogen-only pill (levonorgestrel).
    Lakha F; Ho PC; Van der Spuy ZM; Dada K; Elton R; Glasier AF; Critchley HO; Williams AR; Baird DT
    Hum Reprod; 2007 Sep; 22(9):2428-36. PubMed ID: 17609247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levonorgestrel--implant. Jadelle, Norplant-2.
    Drugs R D; 2002; 3(6):398-400. PubMed ID: 12516944
    [No Abstract]   [Full Text] [Related]  

  • 14. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
    Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
    Coukell AJ; Balfour JA
    Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norplant vs oral contraceptives.
    Slawson DC; Shaughnessy AF
    J Fam Pract; 1994 Jun; 38(6):631-2. PubMed ID: 8195741
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
    López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
    J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    Cromer BA; Stager M; Bonny A; Lazebnik R; Rome E; Ziegler J; Debanne SM
    J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
    Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
    Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.